Understanding the promising role of antibody drug conjugates in breast and ovarian cancer

A nascent category of anticancer therapeutic drugs called antibody-drug conjugates (ADCs) relate selectivity of aimed therapy using chemotherapeutic medicines with high cytotoxic power. Progressive linker technology led to the advancement of more efficacious and safer treatments. It offers neoteric...

Descripción completa

Detalles Bibliográficos
Autores principales: Babbar, Ritchu, Vanya, Bassi, Aarti, Arora, Rashmi, Aggarwal, Ankur, Wal, Pranay, Dwivedi, Sunil Kumar, Alolayan, Salma, Gulati, Monica, Vargas-De-La-Cruz, Celia, Behl, Tapan, Ojha, Shreesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660083/
https://www.ncbi.nlm.nih.gov/pubmed/38027672
http://dx.doi.org/10.1016/j.heliyon.2023.e21425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660083/
https://www.ncbi.nlm.nih.gov/pubmed/38027672
http://dx.doi.org/10.1016/j.heliyon.2023.e21425

Ejemplares similares